UB Paderborn / Katalog / Suche / in CDI

Get reliable laboratory findings - how to recognize the deceptive effects of angiotensin-converting enzyme inhibitor therapy in the laboratory diagnostics of sarcoidosis?

Clinical chemistry and laboratory medicine, 2024-06, Vol.62 (7), p.1393

2024

Link zum Volltext

Verfügbarkeit prüfen

Optimized angiotensin-converting enzyme activity assay for the accurate diagnosis of sarcoidosis

Clinical chemistry and laboratory medicine, 2018-06, Vol.56 (7), p.1117

2018

Link zum Volltext

Verfügbarkeit prüfen

Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections

Liver international, 2012-04, Vol.32 (4), p.603-611

2012

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Target Sites of Nitric Oxide in Photosynthetic Electron Transport as Studied by Chlorophyll Fluorescence in Pea Leaves

Plant physiology (Bethesda), 2008-04, Vol.146 (4), p.1920-1927

2008

Link zum Volltext

Verfügbarkeit prüfen

Utility of serological markers in inflammatory bowel diseases: gadget or magic?

World journal of gastroenterology : WJG, 2007-04, Vol.13 (14), p.2028

2007

Link zum Volltext

Verfügbarkeit prüfen

Presence of anti-microbial antibodies in liver cirrhosis--a tell-tale sign of compromised immunity?

PloS one, 2010-09, Vol.5 (9), p.e12957-e12957

2010

Link zum Volltext

Verfügbarkeit prüfen

Catheter-directed thrombolysis in inflammatory bowel diseases： Report of a case

World journal of gastroenterology : WJG, 2012-09, Vol.18 (34), p.4791-4793

2012

Link zum Volltext

Verfügbarkeit prüfen

Combined application of angiotensin converting enzyme and chitotriosidase analysis improves the laboratory diagnosis of sarcoidosis

Clinica chimica acta, 2020-01, Vol.500, p.155-162

2020

Link zum Volltext

Verfügbarkeit prüfen

Chitotriosidase gene polymorphisms and mutations limit the determination of chitotriosidase expression in sarcoidosis

Clinica chimica acta, 2021-02, Vol.513, p.50-56

2021

Link zum Volltext

Verfügbarkeit prüfen

Fontolizumab in moderate to severe Crohn's disease: A phase 2, randomized, double‐blind, placebo‐controlled, multiple‐dose study

Inflammatory bowel diseases, 2010-02, Vol.16 (2), p.233-242

2010

Link zum Volltext

Verfügbarkeit prüfen

Anti-microbial antibodies in celiac disease： Trick or treat

World journal of gastroenterology : WJG, 2009-08, Vol.15 (31), p.3891-3900

2009

Link zum Volltext

Verfügbarkeit prüfen

norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis

Journal of hepatology, 2017-09, Vol.67 (3), p.549-558

2017

Link zum Volltext

Verfügbarkeit prüfen

Phenotypic polymorphism of haptoglobin: A novel risk factor for the development of infection in liver cirrhosis

Human immunology, 2011-04, Vol.72 (4), p.348-354

2011

Link zum Volltext

Verfügbarkeit prüfen

The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

Journal of hepatology, 2020-10, Vol.73 (4), p.842-854

2020

Link zum Volltext

Verfügbarkeit prüfen

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

The New England journal of medicine, 2019-09, Vol.381 (13), p.1201-1214

2019

Link zum Volltext

Verfügbarkeit prüfen

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

The New England journal of medicine, 2019-09, Vol.381 (13), p.1215-1226

2019

Link zum Volltext

Verfügbarkeit prüfen

PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

Journal of hepatology, 2021-05, Vol.74 (5), p.1097-1108

2021

Link zum Volltext

Verfügbarkeit prüfen

ERCP is more challenging in cases of acute biliary pancreatitis than in acute cholangitis – Analysis of the Hungarian ERCP registry data

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2021-01, Vol.21 (1), p.59-63

2021

Link zum Volltext

Verfügbarkeit prüfen

Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis

The New England journal of medicine, 2021-09, Vol.385 (14), p.1280-1291

2021

Link zum Volltext

Verfügbarkeit prüfen

A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED)

The American journal of gastroenterology, 2013-12, Vol.108 (12), p.1877-1888

2013

Link zum Volltext

Verfügbarkeit prüfen

Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort

Human immunology, 2010-04, Vol.71 (4), p.407-413

2010

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the Combined Application of Ethanol-Fixed and Formaldehyde-Fixed Neutrophil Substrates for Identifying Atypical Perinuclear Antineutrophil Cytoplasmic Antibodies in Inflammatory Bowel Disease

Clinical and Vaccine Immunology, 2009-04, Vol.16 (4), p.464-470

2009

Link zum Volltext

Verfügbarkeit prüfen

Budesonide 9 mg Is at Least as Effective as Mesalamine 4.5 g in Patients With Mildly to Moderately Active Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2011-02, Vol.140 (2), p.425-434.e1

2011

Link zum Volltext

Verfügbarkeit prüfen

Haptoglobin polymorphisms are associated with crohn's disease, disease behavior, and extraintestinal manifestations in hungarian patients

Digestive diseases and sciences, 2007-05, Vol.52 (5), p.1279-1284

2007

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Get reliable laboratory findings - how to recognize the deceptive effects of angiotensin-converting enzyme inhibitor therapy in the laboratory diagnostics of sarcoidosis?

Optimized angiotensin-converting enzyme activity assay for the accurate diagnosis of sarcoidosis

Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections

In Vivo Target Sites of Nitric Oxide in Photosynthetic Electron Transport as Studied by Chlorophyll Fluorescence in Pea Leaves

Utility of serological markers in inflammatory bowel diseases: gadget or magic?

Presence of anti-microbial antibodies in liver cirrhosis--a tell-tale sign of compromised immunity?

Catheter-directed thrombolysis in inflammatory bowel diseases： Report of a case

Combined application of angiotensin converting enzyme and chitotriosidase analysis improves the laboratory diagnosis of sarcoidosis

Chitotriosidase gene polymorphisms and mutations limit the determination of chitotriosidase expression in sarcoidosis

Fontolizumab in moderate to severe Crohn's disease: A phase 2, randomized, double‐blind, placebo‐controlled, multiple‐dose study

Anti-microbial antibodies in celiac disease： Trick or treat

norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis

Phenotypic polymorphism of haptoglobin: A novel risk factor for the development of infection in liver cirrhosis

The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

ERCP is more challenging in cases of acute biliary pancreatitis than in acute cholangitis – Analysis of the Hungarian ERCP registry data

Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis

A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED)

Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort

Evaluation of the Combined Application of Ethanol-Fixed and Formaldehyde-Fixed Neutrophil Substrates for Identifying Atypical Perinuclear Antineutrophil Cytoplasmic Antibodies in Inflammatory Bowel Disease

Budesonide 9 mg Is at Least as Effective as Mesalamine 4.5 g in Patients With Mildly to Moderately Active Crohn's Disease

Haptoglobin polymorphisms are associated with crohn's disease, disease behavior, and extraintestinal manifestations in hungarian patients

Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe--a Hungarian nationwide observational study

Suchergebnisse filtern